Home › Ewing Sarcoma › Maryland
Ewing Sarcoma clinical trials in Maryland
4 studies for Ewing Sarcoma are looking for participants at sites in Maryland.
Cities in Maryland
Evaluation of Xaluritamig in Adults, Adolescents and Children With Relapsed or Refractory Ewing Sarcoma (EWS)
- Johns Hopkins University, Baltimore
RecruitingPhase 1
Ages 2 and older · All sexes · Updated Sep 25, 2026 · NCT07297979Targeted Oligometastatic Radiation in Pediatric and Young Adult Patients With Soft Tissue and Bone Sarcoma
- Johns Hopkins Hospital, Baltimore
Recruiting
Up to age 39 · All sexes · Updated Jul 13, 2026 · NCT06796543Reduced Intensity Haploidentical BMT for High Risk Solid Tumors
- The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore
RecruitingPhase 2
Ages 1 to 50 · All sexes · Updated Mar 13, 2026 · NCT01804634Study of Lurbinectedin Monotherapy in Pediatric and Young Adult Participants With Relapsed/Refractory Ewing Sarcoma
- Johns Hopkins University, Baltimore
RecruitingPhase 1/2
Ages 2 to 30 · All sexes · Updated Feb 3, 2026 · NCT05734066From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.